Combination of Pembrolizumab and Trastuzumab Shows Early Promise for Patients With Trastuzumab-Resistant Breast Cancer:

Vered Stearns, MD, and Prudence A. Francis, MD, on ER+ Breast Cancer: Controversies in Adjuvant Treatment:

Meredith M. Regan, ScD, on Early Breast Cancer: Update on the TEXT and SOFT Trials:


ASCO Post video of Hal Burstein on SOFT:

ETOP IBCSG Partners Foundation
Effingerstrasse 33
3008 Bern, Switzerland

Phone: +41 31 511 94 00

Member Login